Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Biden just spoke about the Chip Act plugging Intel and introducing the Intel CEO in the audience during his State of the Union speech.
Congrats on end of May retirement. My hope for the Lebby timeline is a little different. I’m 86 years old with severe heart problems for the last 3 years.
I have moved my hope and expectation up to achieving the DEAL(s?) before the end of April. My thinking is that protocol will expect the next quarter’s report and conference call in mid to late May (don’t ask me how that will coordinate with the expected ASM). I’m counting on Lebby’s reputation to want to surprise and overachieve. I can’t believe he would want to stand up for those reports and try to explain why there was no DEAL.
The 2020 annual report appeared on March 31, 2021 and they march toward a share price of 20 didn’t begin until June of 2021.
I’m pretty sure they can craft a very positive annual report by late March this year, but just as with last year they’re going to need MORE to boost the share price toward the $30plus share price many are looking for in 2022. Do you see any other launching pad for this year besides the obvious announcement of a commercial DEAL?
If Lebby and Marcelli want to earn their 2022 sales incentive bonuses, I would think the sooner the DEAL is announced, the more time that is left to exceed the bonus target goals. Is it possible that we could have a DEAL announcement before the 2021 annual report is released?
Thanks for responding to my question about the quarterly conference call that is normal procedure. I’m wondering if the delay is because they are preparing an annual report rather than a quarterly report. Companies often take extra time when they are going to release an annual report. That could put the report in the mid to late March time period.
The idea that they are exempt because they have no earnings is bogus because that would have eliminated most of the young biotechs who have no earnings to report but still run conference calls every quarter.
I’m leaning toward the annual report explanation right now. I have no idea how that might affect the ASM, but if there is a deal consummated before May and analysts have been assigned to coverer LWLG, the meeting will have to have an open invitation to those analysts I would assume which would most likely change the meeting to “official” from the informal environment that has been described in the past. I have never attended because of health problems, but have followed through IHub.
Can someone tell me why there seems to be no expectation for a quarterly earnings conference call for LWLG?
I’ve been buying stocks for nearly 40 years and I can’t remember a stock that did not report earnings, quarterly accomplishments, and usually quarterly and yearly goals as well as taking questions from analysts and sometimes shareholders.
On Nov. 16, LWLG gave a quarterly update and I assumed it was short and sweet because they had only been active in NASDAQ for about a month at that time. It has now been a full quarter since that report and all the other stocks I own are having or planning to report to their shareholders.
Please tell me what exempts LWLG from doing the same.
Does anyone have information about when the Last quarter’s conference call will take place. I assumed it would be in mid-February sometime. I believe all NASDAQ firms are expected to provide updates about the achievements and future plans as well as answer questions from institutional representatives and sometimes shareholders. They issued a report last quarter, but it was after or just one month on NASDAQ so it didn’t provide much useful information, but I would think they must speak more directly to many of the questions that are being hashed and rehashed on this board.
Does anyone have information about when the Last quarter’s conference call will take place. I assumed it would be in mid-February sometime. I believe all NASDAQ firms are expected to provide updates about the achievements and future plans as well as answer questions from institutions covering the company. They issued a report last quarter, but it was for just one month on NASDAQ so it didn’t provide much useful information, but I would think they must speak more directly to many of the questions that are being hashed and rehashed on this board.
Do you or any of the old timers here know what year Terry Hallinihan passed away? My memory is so bad now, and I followed him over to this board from a different biotech message board about a year and a half before he died.
TIA
What we need now are a couple of institutions to start coverage with analyst projections (hopefully done before the end of the year).
I believe (by protocol) this would require LWLG to host a conference call when they make their quarterly report in February. This would include a Q & A session for interested institutions. It might also elicit more specific projections from the company.
Ive been reading about “DEALTIME” for way too long. I assume DEAL means contracts, licenses, revenue numbers, partnerships, or other specific goodies.
We rang the NASDAQ bell in late September. That means we have been a full member during the entire final calendar quarter of 2021. Therefore, protocol would indicate that LWLG should host a quarterly report/conference call (probably in Feb. 2022).
My hope and expectation is that LWLG will follow the typical transparent format used by most NASDAQ companies. They would highlight significant events from the last 3 months and list some goals for the next quarter or year. They would list current financial status and make some financial projections for the next quarter or year. They would end by opening up the call for a Q & A session with analysts, industry or fund representatives, etc.
I would much rather host this kind of meeting with a signed DEAL in hand than without. Please let me know how your expectations are different from mine.
X I am aware of the ASM activities in the past although I’ve never attended.
I’m wondering if we grow into the company we want to be and we’re being followed by all sorts of institutions, analysts, etc….won’t they be expecting quarterly and yearly meetings and conference calls with all the trappings such as highlights for the quarter, projections into the future, financial data, and a question and answer period? If so, might this then eliminate or alter the ASM we’ve been used to?
I have seen a number of references to the ASM next year in May.
My question relates to the NASDAQ status now. Is it not traditional for each company to have three quarterly reports and one year end report each year?
If LWLG wanted to have a year end report in May, this would seem to mean that they would need to make the calendar year first quarter represent the final quarter for their reporting year which I believe is possible, but has anyone seen this in writing?
What news?
In order to generate any meaningful revenue, they need the FDA approval they've screwed up for months. If they received FDA notification of any kind they're obligated to report that within a couple f days.
Therefore, tell me where the revenue is going to comefrom this quarter???
I don't understand the lack of interest. Multiple analysts project a stock price average of $18.50 within a year.
Is there a different message board somewhere with an interested discussion group?
Does anyone have a catalyst in mind that would rejuvenate interest in this stock?
Global Foundry CEO: We're sold out of semiconductor chip capacity through 2023.
I'm over my head with this shelf. If a shareholder or institution
can buy a share for about $10, where does buying 10M shares at $100 a share make any sense?
Sorry to be so far out of the loop, but I'd like some brief explanation where and when all this millions of dollars being projected willappear.
TIA
I appreciate your detailed response. It was way more than I expected. Thank you.
I go back to the BTX time and an introduction to the company from John Mauldin and a biotech consultant named Cox. I do not have a strong scientific background so I just sort of lurked on the wall, waiting for the communication crumbs that drop now and then. I'm 85 years old and have had some severe medical problems that last 2 years, but am trying to get back in action a litttle recently.
With limited knowledge and time, I'm not going to try for more depth in you detailed scientific swamp. I'll wait and observe.
One question more. I haven't paid any attention to OCX, but it seems that LCTX has some irons in the fire that might provoke some investment possibilitieis ...but again how soon??? Do you think that any of the three LCTX strands could produce any revenue in the next three to rour years.
I'm legally blind using special computer programing from the VA so if I've made typing errors, please excuse.
Any information about Juvenescence and some actual revemue efforts in the next year? Or do we just remain a science research center with no hope for a stock that might have some market value in the next few years?
With a $50M package for them in 2019, might one hope for some actual plans, timelines, goals, etc. being communicated to shareholders as if this was an actual investment vehicle rather than the science project that seems to be the message so far.
Thank you for your assistance on my previous question.
I'm seeking help again. I own some NDRAW warrants. During the last few years, I've been inactive because of medical problems. I now discover that sometime in the interim, I accumulated some NWDVW warrants My brokerage statement says they are worth 2 cents on lessthan 100 warrants and that my loss on the gain area on the website amounts to many thousands of dollars.
Any clarification you can provide would be greatly appreciated before I try to clarify the situation with my online broker. Especially any website with information. I really have no idea what/s going on here.
TIA
d
v
w
I'm seeking information about the warrants. nDRAW
I own some warrants from a few years ago. I had medical problems for about 1 1/2 years and am back trying to get into problems in my portfolio.
I have a great deal of trouble with the NDRA website.
Thanks in advamce fpr amy website or source of information about these warrants outstanding ...anything about their term length, expiration dates, or assistance of any type.
TIA
Very dead board, but I'll try once more.
I have felt for a couple of years that this is a very interesting biotech heading toward two phase 3 studies next year that both will have short time data collection periods leading to possible major deciions.
Company history highlighted by 50 years of research in the Pacific region.
May 6 company conference call initiated a sell off that seems to be a good entry point unless someone can explain to me what item in the call initiated the sell off. I cannot detect a red flag in the transcript of the call.
What happened to the big plans with Juvenesence? I thought the billionaire was going to take over the biotech world. LCTX seems to have something resembling a weak pulse, but AGE seems to be a moribund research project.
I have both children and grndchildren who have done well financially on their own, but I'm sure some extra padding would be appreciated in the long run.
I especially wanted to thank you for your exceptional sharing of information over the years. It has been an unusual journay for many of us.
Very sorry for the spelling distractions. My explanation is that I'm about 86 years old with a long history of deteriorating heart problems, but more directly I became legally blind about a year and a half ago through unsuccessful surgery. The VA has provided me with a computer and special software that helps me surf with sound and extreme magnification tools.
With my short length of life expectation, I'm growing increasingly nervouse that I won't live to see any actual commercialization.
I think we obviously need to jump through all the tier 1 NDA hoops and delays, but I'm questioning that path as being the best or most efficient path. Time is not a friend to the very small company trying to impact this huge market. Historh presents a gigantic list of ways this approach can end badly.
We all hope we're nearing the end time for this process. That means someone has to ask for the order...assume responsibility for closing the sale...in my terminolgy. People who don't sell everyday often avoid this responsibility in every way the can. This involves finding people who have enough power to say "yes" in the first instance and then directly asking for the order. All the technical and scientific information is important, but nothing is as crucial for my peace of mind as finding out that we really have some people who are very active in searching for buyers who have enough power to close the deal.
I'm afraid I see way too much expectations pointed at the tier 1 NDA ass kissing...and not the aggessive and direct smooth confrontation depicted by most people used to asking for the order.
Sorry if my bluntness is offputing or for any misspellings. What do you expect from a dying blind man at this stage of the process?
I hope your dreams here are realized. I have skin in this game and will benefit if you are correct. I do hope we are close, and I think something prior to May 27 would really be a supper opportune time for a BIG announcement.
We have been talking about commercialization for quite some time now. This will depend on TWLG closing the sale. This means there is a press lelease with company or companies that specify revenues or other forms of remuneration changing hands for TWLY benefit.
What I'm sure of is that everyone wants to experience the closing. The question I'm asking is...would you rather start out trying to close a sale in the $10 M, $200M, or the $100B category. I would feel more comfortable with starting at the lower numbers. I'm not particular or even knowledgeable about a prefered appoach among licensing, partnerships, or manufacturing, but I would feel more comfortable if I knew we were making concerted efforts with samaller entities in this large arena.
I grow more and more fearfull every day we allow these predatory populated tier 1 massive forces to hide everything under the NDA umbrella and plan how to do what so many Big tech have done to the smaller upcomers in so many devious ways. A licensing closing with 2 or three smaller entities would allow them to publicize their and TWLG's strengths to the world in a way that would apply more pressure to the secretive tier 1's.
We've been talking about commercialization for quite qhile. I'm a very old man with a basic question. What is the most likely path to closing this sale. Our path through the bureacratic tier 1 NDA controlled maze seems a long shot to me. I'm not going to go through the long history of the Big tech companies growing more through the predator route as it applies to innovative small companies.
Someone explain to me why we shouldn't be working at "closing" possibilities with smaller entities with actual revenue proeducing fola enumerated in an official document that could be shared with the world. No NDA hiding. Get started. Get something out in the open with licensing, partnerships, or manufacturing wo there are actually people able to talk about our devices in public and stir up some actual commercial activity. Let the NDA move along at their pact, but focus our main "closing" activity on the doable.
Preferably find a "non Chinese HG" and close the deal.
I am afraid that if TWLG has real value, there is the likelihood we willl encounter a multitude of tier 1 predators way before they find a powerful decision making bureaucrat who will make a closing fair offer and that sure isn't going to be in the $100 or even the $20 range for a $1 company.
Please convince me there is a logical expectation for placing so much emphasis on the NDA tier 1 approach for a successful closing effort.
They must have said something at the H.C. Wainwright. I don't have time to access it now.
Sorry about that Scope. Terry it was. Great communicator. Since we were both Korean War vets, I think he would understand my weakness in remembering names at my age of 85.
Now is the time to begin discussing and planning LIGHTWAVE LOGIC FOR DUMMIES.
Why? YES, I need it and so will a huge majority of potential investors. YES, I don’t trust MZ Group’s competence,and YES, and most important, it could provide rocket fuel for LWLG’s share price.
I know. Curiosity, but plenty of doubt. Please hear me out.
I am a lurker. Terry Hallahans enthusiasm led me to this board about a year before he died. I have ended up owning more of the stock than I could have imagined when I was first introduced to it. I appreciate all of the information that has been shared. Just so you know I am an old geezer with little technical knowledge or background. I’d say I understand about one fourth of what I read here.
Let’s be clear. No change to this site. Just keep on, keeping on.
But if the world is changing as we hope, then maybe a different data matrix is demanded.
Dr. Lebby has led us to the “here and now.” Question is if we really are “here” how do we maximize the now?
Let’s say it really happens.
A press release from the company appears that uses words like revenue, partnerships, licensing, or even the names of recognizable tier 1 companies. CNBC, the WSJ, and even RobinHood hears the news. What do we really need most at that point?
We need many many investors. They need just enough data to awaken the impulse to jab that BUY button.
Think volume, think momentum, think trending. The FOR DUMMIES in the opening was just shock value. I’d much rather that any data generated be part of a moder total marketing plan. Too big of a challenge? Let’s generate some ideas and see where we end up.
A little over a year ago, one of your board leaders anticipate the need for simpler/shorter when he posted his famous ELEVATOR PITCH.
Let’s improve the data flow. Just remember we’re not writing for your coworkers or other techies. Our audience is the guy WITH MONEY who sees the word “silicon” and automatically thinks of breast enhancement or the guy who sees co-packaging and thinks it means putting the hamburger and the french fries in the same sack.
Enough fun. Everyone knows technology is changing their world. They don’t feel competent to participate many times.
Think of your best friend or a close relative that you’re wishing to interest in Lightwave. What approach or topic do you think would work best ? Write it down and share it with us. We’re brainstorming and not expecting final edited copy.
I am planning to submit one more entry with more specific details and examples of my thought direction shortly.
Will MRKR have a quarterly earnings conference call in February?
Confusion regarding AgeX and LCTX collaboration/competition
LCTX states
"We have entered into three separate agreements with entities in the cell therapy space for the license, development, manufacture and sale of products based on our broad cell therapy platform and technologies."
Subsequently on 12/30 AgeX states...
" Going forward we plan to strengthen our capacity of executing on external licensing and collaboration deals with third parties as well as in-house cell therapy product development."
Does anyone have a clear idea or a website that explains who is selling what? When AgeX split from BTX/LCTX who owns the rights to which patents, etc.?
Any clarification would be greatly appreciated.
NOTE: I'm posting this on both the LCTX and the AgeX sites.
LCTX states
"We have entered into three separate agreements with entities in the cell therapy space for the license, development, manufacture and sale of products based on our broad cell therapy platform and technologies."
Subsequently on 12/30 AgeX states...
" Going forward we plan to strengthen our capacity of executing on external licensing and collaboration deals with third parties as well as in-house cell therapy product development."
Does anyone have a clear idea or a website that explains who is selling what? When AgeX split from BTX/LCTX who owns the rights to which patents, etc.?
Any clarification would be greatly appreciated.
NOTE: I'm posting this on both the LCTX and the AgeX sites.
How do you see this playing out in the near term? What benefits will accrue to the company, the shareholders, the warrant holders, etc.?
This comment from the Seeking Alpha article is particularly confusing.
"The company won't receive any proceeds from stock sales, but could receive proceeds from the exercise of warrants."
Can anyone explain what just happened with the appearance of these 25.6M shares???
Provisional Approval??
My understanding is that there is a new process in Australia that can accelerate the approval of promising drugs after a successful Phase 2 study whereby you can begin selling the drug and continue collecting data into a phase 4 to achieve final approval.
Since DMAC increased the stroke study to 100 patients which is supposed to report topline phase 2 results data in 1Q/20, I'm wondering if they are applying for this "provisional approval?"
Any information or thoughts about this possibility would be appreciated.
I just noticed on the Bloomberg website that it lists Press Releases for Lincoln Park Capital Fund LLC for the last 6 months...about 10 different companies are named.
As a more recent investor in LWLG than many of you, I was wondering if LPC in the past has loaned money to any significantly successful listed companies.
At the LPC website there is this description seeming to promote expertise with life sciences: "The Lincoln Park Capital Scientific Advisory Board (SAB) is composed of leading life scientists and medical professionals with years of experience in both research and clinical studies. SAB members are chosen for their diverse backgrounds and experience in relevant scientific and clinical practice areas." Photonics as a life science???
Any history or clarifications would be appreciated.
Very quiet here. Everyone sell and leave??
I was actually surprised at the details on the September 9 presentation at Rodman.
Unlike their earlier presentations, this presentation looks more like a legitimate business presentation. They even include a section regarding ANTICIPATED SIX MONTHS MILESTONES. Now let's us see how accountable to fulfilling those MILESTONES. Let's hope there are more ACCOMPLISHED checks than DELAYED OR DROPPED messages after 6 months.
I'm particularly interested in the RENELON category after all the hoopla a couple of years ago.
That's what we need. A BIDDING WAR.
As shareholders, let's press the issue. If no commercial deal is CLOSED by end of year, let's put it up as a shareholder vote. We want an auction or multiple auctions for separate industries/partnerships...whatever. If we have run the GOO through all the tests, and we can't find a way to CLOSE a deal with all these Tier 1's...maybe an auction with a deadline date will create a BIDDING WAR.
What could be better than a BIDDING WAR?
If we look at last quarterly reports of LCTX, AGE, OCX, do we find any real commercial activity. I see managerial musical chairs, lots of questionable scientific experiments, location moving and disruption, ringing of bells at stock exchanges, and no meaningful timelines leading to revenues.
I once had a hope that Juvenescene would bring some business focus and expertise that would change the culture that has led this BTX empire from a scientists playground into almost oblivion.
Question! Why do any of you still own any of these stocks. I'm preparing to jump ship after waiting, waiting, waiting???
What hopes or catalysts over the next 12 months are convincing to you that make you maintain your positions in any of these enterprises...given the pathetic nature of these quarterly reports?